Description:

ANHL01P1: Relapse/Progression Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma NCT00057811 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3BA73-F2E0-23C7-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3BA73-F2E0-23C7-E034-0003BA12F5E7
Keywords:
  1. 8/27/12 8/27/12 -
  2. 5/20/15 5/20/15 - Martin Dugas
Uploaded on:

May 20, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

B-Cell Leukemia or Lymphoma Relapse/Progression ANHL01P1 NCT00057811

No Instruction available.

  1. StudyEvent: ANHL01P1: Relapse/Progression
    1. No Instruction available.
Header
Disease progression
Relapse / Progression (Required field)
Was a biopsy performed to document the relapse/progression? (Required field)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial